Quarterly report [Sections 13 or 15(d)]

Revenue

v3.26.3
Revenue
 9 Months Ended
Sep. 30, 2026
Revenue Recognition [Abstract]  
Revenue Revenue
The following table presents the Company’s disaggregated revenue by offering type (in thousands):
Three Months Ended
September 30,
2026 2025
Total Net
Revenues
Percentage of
Total Net
Revenues
Total Net
Revenues
Percentage of
Total Net
Revenues
Patient Services revenue recognized at a point in time:
Direct products $ 662  1.8  % $ 690  1.9  %
Third-Party Payer products 6,848  18.2  % 4,822  13.2  %
Patient Services revenue recognized over time:
Direct rental services 2,081  5.5  % 1,985  5.4  %
Third-Party Payer rental services 13,673  36.4  % 12,723  34.9  %
Total Patient Services accounted for under ASC 606 23,264  61.9  % 20,220  55.4  %
Device Solutions revenue recognized at a point in time:
Products 3,324  8.9  % 4,100  11.2  %
Services
 2,412  6.4  % 3,379  9.3  %
Device Solutions revenue recognized over time:
Services
 312  0.8  % 1,263  3.5  %
Total Device Solutions accounted for under ASC 606 6,048  16.1  % 8,742  24.0  %
Total Revenue Accounted for under ASC 606 29,312  78.0  % 28,962  79.4  %
Patient Services lease revenue
 2,547  6.8  % 2,144  5.9  %
Device Solutions lease revenue
 5,730  15.2  % 5,382  14.8  %
Total Revenue accounted for under ASC 842, Leases 8,277  22.0  % 7,526  20.6  %
Total Net Revenue $ 37,589  100.0  % $ 36,488 100.0  %
Nine Months Ended
September 30,
2026 2025
Total Net
Revenues
Percentage of
Total Net
Revenues
Total Net
Revenues
Percentage of
Total Net
Revenues
Patient Services revenue recognized at a point in time:
Direct products $ 2,038  1.9  % $ 1,979  1.8  %
Third-Party Payer products 18,149  16.8  % 12,880  12.0  %
Patient Services revenue recognized over time:
Direct rental services 6,193  5.7  % 5,834  5.4  %
Third-Party Payer rental services 39,409  36.4  % 37,522  35.0  %
Total Patient Services accounted for under ASC 606 65,789  60.8  % 58,215  54.3  %
Device Solutions revenue recognized at a point in time:
Products 10,404  9.6  % 12,567  11.7  %
Services 7,857  7.3  % 8,463  7.9  %
Device Solutions revenue recognized over time:
Services 524  0.5  % 4,866  4.5  %
Total Device Solutions accounted for under ASC 606 18,785  17.4  % 25,896  24.2  %
Total Revenue Accounted for under ASC 606 84,574  78.2  % 84,111  78.5  %
Patient Services Lease Revenue 6,915  6.4  % 6,438  6.0  %
Device Solutions Lease Revenue 16,717  15.4  % 16,657  15.5  %
Total Revenue accounted for under ASC 842, Leases 23,632  21.8  % 23,095  21.5  %
Total Net Revenue $ 108,206  100.0  % $ 107,206 100.0  %

Contract Balances
(dollars in thousands)
As of September 30, 2026
As of December 31, 2025
 $ Change
Accounts receivable, net $ 29,554  $ 22,901  $ 6,653 
Contract assets $ 983  $ 1,244  $ (261)
Contract liabilities $ —  $ 109  $ (109)
The change in contract assets during the nine months ended September 30, 2026 included $2.1 million of revenue recognized for which the payment is subject to conditions other than the passage of time, which was partially offset by $2.4 million of contract assets reclassified to accounts receivable as our right to consideration for these contract assets became unconditional. Contract assets are included in other current assets on the Company's condensed consolidated balance sheets. As of December 31, 2024, accounts receivable, net, and contract assets were $21.2 million and $0.6 million, respectively. As of December 31, 2024, there were no contract liabilities. Revenue recognized during the nine months ended September 30, 2026 that was included in the contract liabilities at the beginning of the period was $0.1 million. The allowance for credit losses was $0.7 million and $0.3 million as of September 30, 2026 and December 31, 2025, respectively.